US Stock MarketDetailed Quotes

Spero Therapeutics (SPRO)

Watchlist
  • 2.750
  • +0.070+2.61%
Close Apr 17 16:00 ET
  • 2.770
  • +0.020+0.73%
Post 20:01 ET
159.20MMarket Cap18.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Spero Therapeutics (SPRO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
117.62%59.62M
323.88%39.66M
-61.02%3.05M
96.14%11.8M
21.57%5.11M
-71.68%27.4M
-86.97%9.36M
-66.56%7.82M
663.58%6.02M
468.11%4.2M
Operating revenue
117.62%59.62M
323.88%39.66M
-61.02%3.05M
96.14%11.8M
21.57%5.11M
-71.68%27.4M
-86.97%9.36M
-66.56%7.82M
663.58%6.02M
468.11%4.2M
Cost of revenue
Gross profit
Operating expense
-47.48%52.46M
-72.68%8.25M
-60.71%10.38M
-43.52%14.16M
8.14%19.67M
42.79%99.88M
41.85%30.2M
31.99%26.41M
83.35%25.08M
21.51%18.19M
Selling and administrative expenses
-10.66%21.18M
-39.06%4.3M
-19.70%4.17M
6.24%5.88M
15.33%6.82M
-7.24%23.7M
9.68%7.06M
-8.93%5.2M
-9.24%5.53M
-19.13%5.92M
-General and administrative expense
-10.66%21.18M
-39.06%4.3M
-19.70%4.17M
6.24%5.88M
15.33%6.82M
-7.24%23.7M
9.68%7.06M
-8.93%5.2M
-9.24%5.53M
-19.13%5.92M
Research and development costs
-60.24%38.47M
-80.61%5.59M
-68.00%8.6M
-55.02%10.67M
-21.50%13.61M
88.10%96.76M
74.16%28.84M
63.87%26.86M
149.47%23.73M
93.03%17.33M
Other operating expenses
65.10%-7.18M
71.18%-1.64M
57.63%-2.39M
42.89%-2.39M
84.93%-763K
-192.09%-20.58M
-235.18%-5.69M
-170.21%-5.65M
-116.80%-4.18M
-280.96%-5.06M
Operating profit
109.88%7.16M
250.64%31.41M
60.58%-7.33M
87.61%-2.36M
-4.11%-14.56M
-370.59%-72.48M
-141.26%-20.85M
-651.39%-18.59M
-47.87%-19.06M
1.72%-13.98M
Net non-operating interest income expense
-46.95%2.51M
-63.42%376K
-54.99%532K
-38.23%740K
-34.89%864K
20.27%4.74M
-1.44%1.03M
24.42%1.18M
22.00%1.2M
37.80%1.33M
Non-operating interest income
-46.95%2.51M
-63.42%376K
-54.99%532K
-38.23%740K
-34.89%864K
20.27%4.74M
-1.44%1.03M
24.42%1.18M
22.00%1.2M
37.80%1.33M
Other net income (expense)
-2.57%-838K
0
-2,150.00%-585K
-8,000.00%-79K
-1,142.86%-174K
84.64%-817K
-26,033.33%-778K
99.51%-26K
116.67%1K
-600.00%-14K
Special income (charges)
3.65%-845K
--0
---587K
---83K
---175K
83.47%-877K
---877K
--0
--0
--0
-Less：Restructuring and merger&acquisition
-70.58%258K
--0
--0
--83K
--175K
--877K
--877K
--0
--0
--0
-Less:Impairment of capital assets
----
----
--587K
----
----
--0
--0
--0
----
----
-Write off
--587K
--0
--587K
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
-88.33%7K
--0
107.69%2K
300.00%4K
107.14%1K
528.57%60K
3,200.00%99K
-160.00%-26K
116.67%1K
-600.00%-14K
Income before tax
112.88%8.83M
254.29%31.78M
57.66%-7.38M
90.48%-1.7M
-9.45%-13.87M
-369.90%-68.57M
-139.94%-20.6M
-1,654.23%-17.44M
-49.92%-17.86M
4.50%-12.67M
Income tax
261K
-10.00%261K
0
0
-25.06%290K
-113.12%-290K
Net income
112.50%8.57M
250.90%31.52M
56.95%-7.38M
90.48%-1.7M
-9.45%-13.87M
-400.65%-68.57M
-140.80%-20.89M
-435.01%-17.15M
-49.92%-17.86M
4.50%-12.67M
Net income continuous Operations
112.50%8.57M
250.90%31.52M
56.95%-7.38M
90.48%-1.7M
-9.45%-13.87M
-400.65%-68.57M
-140.80%-20.89M
-435.01%-17.15M
-49.92%-17.86M
4.50%-12.67M
Minority interest income
Net income attributable to the parent company
112.50%8.57M
250.90%31.52M
56.95%-7.38M
90.48%-1.7M
-9.45%-13.87M
-400.65%-68.57M
-140.80%-20.89M
-435.01%-17.15M
-49.92%-17.86M
4.50%-12.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
112.50%8.57M
250.90%31.52M
56.95%-7.38M
90.48%-1.7M
-9.45%-13.87M
-400.65%-68.57M
-140.80%-20.89M
-435.01%-17.15M
-49.92%-17.86M
4.50%-12.67M
Basic earnings per share
111.81%0.15
247.37%0.56
59.38%-0.13
90.91%-0.03
-4.17%-0.25
-395.35%-1.27
-139.18%-0.38
-433.33%-0.32
-43.48%-0.33
4.00%-0.24
Diluted earnings per share
111.81%0.15
239.47%0.53
59.38%-0.13
90.91%-0.03
-4.17%-0.25
-395.35%-1.27
-139.18%-0.38
-433.33%-0.32
-43.48%-0.33
4.00%-0.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 117.62%59.62M323.88%39.66M-61.02%3.05M96.14%11.8M21.57%5.11M-71.68%27.4M-86.97%9.36M-66.56%7.82M663.58%6.02M468.11%4.2M
Operating revenue 117.62%59.62M323.88%39.66M-61.02%3.05M96.14%11.8M21.57%5.11M-71.68%27.4M-86.97%9.36M-66.56%7.82M663.58%6.02M468.11%4.2M
Cost of revenue
Gross profit
Operating expense -47.48%52.46M-72.68%8.25M-60.71%10.38M-43.52%14.16M8.14%19.67M42.79%99.88M41.85%30.2M31.99%26.41M83.35%25.08M21.51%18.19M
Selling and administrative expenses -10.66%21.18M-39.06%4.3M-19.70%4.17M6.24%5.88M15.33%6.82M-7.24%23.7M9.68%7.06M-8.93%5.2M-9.24%5.53M-19.13%5.92M
-General and administrative expense -10.66%21.18M-39.06%4.3M-19.70%4.17M6.24%5.88M15.33%6.82M-7.24%23.7M9.68%7.06M-8.93%5.2M-9.24%5.53M-19.13%5.92M
Research and development costs -60.24%38.47M-80.61%5.59M-68.00%8.6M-55.02%10.67M-21.50%13.61M88.10%96.76M74.16%28.84M63.87%26.86M149.47%23.73M93.03%17.33M
Other operating expenses 65.10%-7.18M71.18%-1.64M57.63%-2.39M42.89%-2.39M84.93%-763K-192.09%-20.58M-235.18%-5.69M-170.21%-5.65M-116.80%-4.18M-280.96%-5.06M
Operating profit 109.88%7.16M250.64%31.41M60.58%-7.33M87.61%-2.36M-4.11%-14.56M-370.59%-72.48M-141.26%-20.85M-651.39%-18.59M-47.87%-19.06M1.72%-13.98M
Net non-operating interest income expense -46.95%2.51M-63.42%376K-54.99%532K-38.23%740K-34.89%864K20.27%4.74M-1.44%1.03M24.42%1.18M22.00%1.2M37.80%1.33M
Non-operating interest income -46.95%2.51M-63.42%376K-54.99%532K-38.23%740K-34.89%864K20.27%4.74M-1.44%1.03M24.42%1.18M22.00%1.2M37.80%1.33M
Other net income (expense) -2.57%-838K0-2,150.00%-585K-8,000.00%-79K-1,142.86%-174K84.64%-817K-26,033.33%-778K99.51%-26K116.67%1K-600.00%-14K
Special income (charges) 3.65%-845K--0---587K---83K---175K83.47%-877K---877K--0--0--0
-Less：Restructuring and merger&acquisition -70.58%258K--0--0--83K--175K--877K--877K--0--0--0
-Less:Impairment of capital assets ----------587K----------0--0--0--------
-Write off --587K--0--587K----------0--0--0--------
Other non- operating income (expenses) -88.33%7K--0107.69%2K300.00%4K107.14%1K528.57%60K3,200.00%99K-160.00%-26K116.67%1K-600.00%-14K
Income before tax 112.88%8.83M254.29%31.78M57.66%-7.38M90.48%-1.7M-9.45%-13.87M-369.90%-68.57M-139.94%-20.6M-1,654.23%-17.44M-49.92%-17.86M4.50%-12.67M
Income tax 261K-10.00%261K00-25.06%290K-113.12%-290K
Net income 112.50%8.57M250.90%31.52M56.95%-7.38M90.48%-1.7M-9.45%-13.87M-400.65%-68.57M-140.80%-20.89M-435.01%-17.15M-49.92%-17.86M4.50%-12.67M
Net income continuous Operations 112.50%8.57M250.90%31.52M56.95%-7.38M90.48%-1.7M-9.45%-13.87M-400.65%-68.57M-140.80%-20.89M-435.01%-17.15M-49.92%-17.86M4.50%-12.67M
Minority interest income
Net income attributable to the parent company 112.50%8.57M250.90%31.52M56.95%-7.38M90.48%-1.7M-9.45%-13.87M-400.65%-68.57M-140.80%-20.89M-435.01%-17.15M-49.92%-17.86M4.50%-12.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 112.50%8.57M250.90%31.52M56.95%-7.38M90.48%-1.7M-9.45%-13.87M-400.65%-68.57M-140.80%-20.89M-435.01%-17.15M-49.92%-17.86M4.50%-12.67M
Basic earnings per share 111.81%0.15247.37%0.5659.38%-0.1390.91%-0.03-4.17%-0.25-395.35%-1.27-139.18%-0.38-433.33%-0.32-43.48%-0.334.00%-0.24
Diluted earnings per share 111.81%0.15239.47%0.5359.38%-0.1390.91%-0.03-4.17%-0.25-395.35%-1.27-139.18%-0.38-433.33%-0.32-43.48%-0.334.00%-0.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -